Innoforce opens GMP manufacturing facility and corp headquarters in Hangzhou, China
The company is investing a total of more than $200 million in its 550,000-square-foot advanced therapies manufacturing base with a full suite of technology platforms
<br />
Innoforce | 02/12/2022 | By Sudeep Soparkar | 462
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy